What is Triangle Biotechnology?
Triangle Biotechnology is at the forefront of simplifying complex and costly life science sample preparation processes. The company offers innovative solutions tailored for DNA shearing for next-generation sequencing, chromatin shearing for ChIP assays, and efficient cell lysis protocols. Their core mission is to accelerate scientific research by delivering sample preparation systems that are not only fast and simple to use but also affordable. By focusing on user-centric design and cost-effectiveness, Triangle Biotechnology aims to empower researchers and foster a deeper understanding of their specific sample preparation challenges.
How much funding has Triangle Biotechnology raised?
Triangle Biotechnology has raised a total of $36K across 1 funding round:
Debt
$36K
Debt (2021): $36K with participation from PPP
Key Investors in Triangle Biotechnology
PPP
Public-Private Partnership
What's next for Triangle Biotechnology?
With the recent substantial expansion capital, Triangle Biotechnology is poised for significant growth. The company's strategic focus will likely involve scaling its production capabilities, enhancing its product development pipeline, and expanding its market reach within the global life sciences research community. This investment at a Series B/C stage suggests a strong validation of their business model and technology, enabling them to further solidify their position as a key player in sample preparation solutions and potentially explore new applications or research areas. The company's commitment to affordability and efficiency is expected to drive adoption and further innovation.
See full Triangle Biotechnology company page
